Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human IL11 Antibody (X203)

Catalog #:   DHD42201 Specific References (51) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHD42201

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Applications

Research Grade Biosimilar

Target

Adipogenesis inhibitory factor, AGIF, IL11, IL-11, Interleukin-11, Oprelvekin

Concentration

3.12 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P20809

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

EnX203, EnX 203, EnX-203, X203

Clone ID

X203

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image
  • Bioactivity
    Detects Human IL11 in indirect ELISAs.
  • Bioactivity
    (F) The percentage of TNF-α+ and IFN-γ+ in CD8+ T cells after treating with supernatant of VSIG4+ macrophages combined with IL-11 neutralizing antibody (100 μg/mL), mean ± SD.
    Data sourced from citation (PMID: 40339578)
References

The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling., PMID:34435951

WNT/β-Catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production., PMID:34576234

Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts., PMID:34651016

A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model., PMID:34667238

Exclusive inhibition of IL-6 trans-signaling by soluble gp130FlyRFc., PMID:34927050

Therapeutic opportunities for senolysis in cardiovascular disease., PMID:35015342

Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome., PMID:35135328

A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome., PMID:35140116

IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy., PMID:35273577

Interleukin-11 drives human and mouse alcohol-related liver disease., PMID:35365572

IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis., PMID:35408908

[Analysis of immune inflammation-related proteins in serum of patients with rheumatoid arthritis and the regulatory effect of Xinfeng Capsule on cytokines]., PMID:35603652

[Correlation between Serum miR-34a Level and Thrombocytopenia after Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma]., PMID:35680806

Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge., PMID:35731866

Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury., PMID:35806094

Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic., PMID:35916739

IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells., PMID:35992082

IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues., PMID:36012165

Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease., PMID:36470928

Neutralization of interleukin-11 attenuates silica particles-induced pulmonary inflammation and fibrosis in vivo., PMID:36503802

IL-11 drives the phenotypic transformation of tracheal epithelial cells and fibroblasts to enhance abnormal repair after tracheal injury., PMID:36758859

IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome., PMID:36924234

Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis., PMID:37555348

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)., PMID:37709297

Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target., PMID:37724596

Targeting IL-11 system as a treatment of pulmonary arterial hypertension., PMID:37949331

Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway., PMID:37962127

Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease., PMID:38217849

Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines., PMID:38323010

Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130., PMID:38338642

Cardiac and Renal Fibrosis, the Silent Killer in the Cardiovascular Continuum: An Up-to-Date., PMID:38392276

IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ., PMID:38455057

Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases., PMID:38627168

Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases., PMID:38886296

Bevacizumab-induced immune thrombocytopenia in an ovarian cancer patient with mixed connective tissue disease: case report and literature review., PMID:38903494

Inhibition of IL-11 signalling extends mammalian healthspan and lifespan., PMID:39020175

Analytical and Clinical Validation of an Automated Microfluidic Interleukin-6 Immunoassay., PMID:39048159

Anti-IL-11 antibody shows anti-ageing properties., PMID:39090176

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy., PMID:39122711

Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing., PMID:39381601

Interleukin-11 receptor is an alternative α-receptor for interleukin-6 and the chimeric cytokine IC7., PMID:39473075

Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy., PMID:39639502

De novo discovery of cyclic peptide inhibitors of IL-11 signaling., PMID:39756345

Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection., PMID:39835136

Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression., PMID:39920693

Interleukin-11 expressed in the polyp-enriched fibroblast subset is a potential therapeutic target in Peutz-Jeghers syndrome., PMID:40070038

AHR Agonist ITE Boosted PD1 Antibody's Effects by Inhibiting Myeloid-Derived Cells Suppressive Cells in an Orthotopic Mouse Glioma Model., PMID:40283908

IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade., PMID:40355638

Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity., PMID:40399681

The Use of Biologics for Thyroid Eye Disease., PMID:40478400

Targeting VSIG4+ tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer. [DHD42201]

Datasheet
$ 370
Product specifications
100 μg 370 1 mg 1480 5 mg 4440

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human IL11 Antibody (X203) [DHD42201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only